跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 47 条关于
“Symrise”
全部
47
临床试验
24
药物
0
机构
4
资讯
19
去年
Symrise Partners with HBC to Expand Marine-Based Health Ingredients Portfolio
11个月前
Symrise Invests in Cellibre to Advance Precision Fermentation Technology for Flavor and Cosmetic Ingredients
去年
Vyepti (Eptinezumab) Demonstrates Efficacy in Phase III SUNRISE Trial for Migraine Prevention
去年
BioVie Launches SUNRISE-PD Trial to Test Novel Anti-inflammatory Approach for Early Parkinson's Disease
去年
Lundbeck's Eptinezumab Shows Strong Efficacy in Asian Chronic Migraine Patients in Phase III SUNRISE Trial
去年
Simris Group ADC Partnership Falls Through as EU Partner Withdraws Following Strategic Review
2年前
Atea's Bemnifosbuvir Fails to Meet Primary Endpoint in Phase 3 COVID-19 Trial
去年
TAR-200 Shows Promising Efficacy and Tolerability in BCG-Unresponsive NMIBC
去年
ESMO 2024: Novel Therapies and Biomarkers Advance Bladder Cancer Treatment
2年前
TAR-200 Shows High Complete Response Rate in BCG-Unresponsive NMIBC
第 1 页,共 2 页
上一页
下一页